Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition
Background: Plausible biological mechanisms underlie possible associations between fatty acids in blood and risk of prostate cancer; epidemiologic evidence for an association, however, is inconsistent. Objective: The objectives were to assess the association between plasma phospholipid fatty acids a...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
_version_ | 1826279686196428800 |
---|---|
author | Crowe, F Allen, N Appleby, P Overvad, K Aardestrup, I Johnsen, N Tjønneland, A Linseisen, J Kaaks, R Boeing, H Kröger, J Trichopoulou, A Zavitsanou, A Trichopoulos, D Sacerdote, C Palli, D Tumino, R Agnoli, C Kiemeney, L Bueno-de-Mesquita, H Chirlaque, M Ardanaz, E Larrañaga, N Quirós, JR Sánchez, M |
author_facet | Crowe, F Allen, N Appleby, P Overvad, K Aardestrup, I Johnsen, N Tjønneland, A Linseisen, J Kaaks, R Boeing, H Kröger, J Trichopoulou, A Zavitsanou, A Trichopoulos, D Sacerdote, C Palli, D Tumino, R Agnoli, C Kiemeney, L Bueno-de-Mesquita, H Chirlaque, M Ardanaz, E Larrañaga, N Quirós, JR Sánchez, M |
author_sort | Crowe, F |
collection | OXFORD |
description | Background: Plausible biological mechanisms underlie possible associations between fatty acids in blood and risk of prostate cancer; epidemiologic evidence for an association, however, is inconsistent. Objective: The objectives were to assess the association between plasma phospholipid fatty acids and risk of total prostate cancer by stage and grade. Design: This was a nested case-control analysis of 962 men with a diagnosis of prostate cancer after a median follow-up time of 4.2 y and 1061 matched controls who were taking part in the European Prospective Investigation into Cancer and Nutrition. The fatty acid composition of plasma phospholipids was measured by gas chromatography, and the risk of prostate cancer was estimated by using conditional logistic regression with adjustment for lifestyle variables. Results: We found a positive association between palmitic acid and risk of total, localized, and low-grade prostate cancer. The risk of prostate cancer for men in the highest quintile compared with the lowest quintile of palmitic acid was 1.47 (95% CI: 0.97, 2.23; P for trend = 0.032). We found an inverse association between stearic acid and the risk of total, localized, and low-grade prostate cancer; men in the highest quintile of stearic acid had a relative risk of 0.77 (95% CI: 0.56, 1.06; P for trend = 0.03). There were significant positive associations between myristic, α-linolenic, and eicosapentaenoic acids and risk of high-grade prostate cancer. Conclusion: The associations between palmitic, stearic, myristic, α-linolenic, and eicosapentaenoic acids and prostate cancer risk may reflect differences in intake or metabolism of these fatty acids between the precancer cases and controls and should be explored further. © 2008 American Society for Nutrition. |
first_indexed | 2024-03-07T00:02:29Z |
format | Journal article |
id | oxford-uuid:766ed103-f5c6-4c59-b7b7-ed1698547c01 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T00:02:29Z |
publishDate | 2008 |
record_format | dspace |
spelling | oxford-uuid:766ed103-f5c6-4c59-b7b7-ed1698547c012022-03-26T20:16:24ZFatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and NutritionJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:766ed103-f5c6-4c59-b7b7-ed1698547c01EnglishSymplectic Elements at Oxford2008Crowe, FAllen, NAppleby, POvervad, KAardestrup, IJohnsen, NTjønneland, ALinseisen, JKaaks, RBoeing, HKröger, JTrichopoulou, AZavitsanou, ATrichopoulos, DSacerdote, CPalli, DTumino, RAgnoli, CKiemeney, LBueno-de-Mesquita, HChirlaque, MArdanaz, ELarrañaga, NQuirós, JRSánchez, MBackground: Plausible biological mechanisms underlie possible associations between fatty acids in blood and risk of prostate cancer; epidemiologic evidence for an association, however, is inconsistent. Objective: The objectives were to assess the association between plasma phospholipid fatty acids and risk of total prostate cancer by stage and grade. Design: This was a nested case-control analysis of 962 men with a diagnosis of prostate cancer after a median follow-up time of 4.2 y and 1061 matched controls who were taking part in the European Prospective Investigation into Cancer and Nutrition. The fatty acid composition of plasma phospholipids was measured by gas chromatography, and the risk of prostate cancer was estimated by using conditional logistic regression with adjustment for lifestyle variables. Results: We found a positive association between palmitic acid and risk of total, localized, and low-grade prostate cancer. The risk of prostate cancer for men in the highest quintile compared with the lowest quintile of palmitic acid was 1.47 (95% CI: 0.97, 2.23; P for trend = 0.032). We found an inverse association between stearic acid and the risk of total, localized, and low-grade prostate cancer; men in the highest quintile of stearic acid had a relative risk of 0.77 (95% CI: 0.56, 1.06; P for trend = 0.03). There were significant positive associations between myristic, α-linolenic, and eicosapentaenoic acids and risk of high-grade prostate cancer. Conclusion: The associations between palmitic, stearic, myristic, α-linolenic, and eicosapentaenoic acids and prostate cancer risk may reflect differences in intake or metabolism of these fatty acids between the precancer cases and controls and should be explored further. © 2008 American Society for Nutrition. |
spellingShingle | Crowe, F Allen, N Appleby, P Overvad, K Aardestrup, I Johnsen, N Tjønneland, A Linseisen, J Kaaks, R Boeing, H Kröger, J Trichopoulou, A Zavitsanou, A Trichopoulos, D Sacerdote, C Palli, D Tumino, R Agnoli, C Kiemeney, L Bueno-de-Mesquita, H Chirlaque, M Ardanaz, E Larrañaga, N Quirós, JR Sánchez, M Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition |
title | Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition |
title_full | Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition |
title_fullStr | Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition |
title_full_unstemmed | Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition |
title_short | Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition |
title_sort | fatty acid composition of plasma phospholipids and risk of prostate cancer in a case control analysis nested within the european prospective investigation into cancer and nutrition |
work_keys_str_mv | AT crowef fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT allenn fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT applebyp fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT overvadk fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT aardestrupi fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT johnsenn fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT tjønnelanda fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT linseisenj fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT kaaksr fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT boeingh fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT krogerj fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT trichopouloua fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT zavitsanoua fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT trichopoulosd fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT sacerdotec fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT pallid fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT tuminor fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT agnolic fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT kiemeneyl fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT buenodemesquitah fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT chirlaquem fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT ardanaze fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT larranagan fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT quirosjr fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition AT sanchezm fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition |